Stefan Irion

Company: BlueRock Therapeutics

Job title: Senior Vice President & Head of Research

Seminars:

Treating Lysosomal Storage Diseases Using iPSC-derived Microglia 3:30 pm

Virtual Presentation Inherited, lysosomal storage diseases (LSDs) are characterized by the pathologic build-up of toxic material in the body’s cells because of a genetic defect resulting in enzyme deficiencies. Microglia, the resident myeloid cells of the brain, are dispersed throughout the brain and microglia progenitors can readily be derived from human induced pluripotent stem cells…Read more

day: Day Two